About Abbott Global Point of Care
Abbott Global Point of Care is a company based in Waukegan (United States) founded in 1900. The company has 2 employees as of April 30, 2024. Abbott Global Point of Care has completed 12 acquisitions, including Binax, CanAm Care and Cholestech. Abbott Global Point of Care offers products and services including i-STAT CHEM8+ Cartridge, CHOLESTECH LDX™ Analyzer, Afinion™ 2, and Panbio™ COVID-19 Antigen Self-Test.
- Headquarter Waukegan, United States
- Employees 2 as on 30 Apr, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Abbott Rapid Diagnostics A/S
-
Annual Revenue
$2.36 B (USD)-4as on Dec 31, 2016
-
Net Profit
$151.18 M (USD)-26as on Dec 31, 2016
-
EBITDA
$119.53 M (USD)-8as on Dec 31, 2016
-
Latest Funding Round
$37.76 M (USD), Grant
Feb 24, 2021
- Investors
-
Employee Count
2
as on Apr 30, 2024
-
Investments & Acquisitions
Binax
& 11 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Abbott Global Point of Care
Abbott Global Point of Care offers a comprehensive portfolio of products and services, including i-STAT CHEM8+ Cartridge, CHOLESTECH LDX™ Analyzer, Afinion™ 2, and Panbio™ COVID-19 Antigen Self-Test.
Delivers rapid blood chemistry and hematology results.
Provides lipid profile and glucose testing quickly.
Enables near-patient testing for various diagnostics.
Detects COVID-19 and influenza from a single swab.
Funding Insights of Abbott Global Point of Care
Investors in Abbott Global Point of Care
Abbott Global Point of Care has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Abbott Global Point of Care
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Abbott Global Point of Care
Abbott Global Point of Care has strategically engaged in corporate development activities, having acquired 12 companies. Notable acquisitions include Binax, CanAm Care and Cholestech.
Investment portfolio details for Abbott Global Point of Care
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Drug research and development services are provided to biopharma firms.
|
Locked | Locked | 2015 | Locked | |
|
Developer of products for the management of osteoporosis
|
Locked | Locked | 2003 | Locked | |
|
Rapid Point-of-Care Coagulation analyzer
|
Locked | Locked | 1997 | Locked |
Complete acquisition details for Abbott Global Point of Care
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Abbott Global Point of Care
Detailed financials for Abbott Global Point of Care
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Abbott Global Point Of Care Comparisons
Peer comparison for Abbott Global Point of Care
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Abbott Global Point of Care
Detailed competitors of Abbott Global Point of Care
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Abbott Global Point Of Care
Complete news archive for Abbott Global Point of Care
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abbott Global Point of Care
Abbott Global Point of Care was founded in 1900 and raised its 1st funding round 100 years after it was founded.
Abbott Global Point of Care is headquartered in Waukegan, United States. It is registered at Waukegan, Illinois, United States.
As of Apr 30, 2024, the latest employee count at Abbott Global Point of Care is 2.
Annual revenue of Abbott Global Point of Care is $2.36B as on Dec 31, 2016.
Abbott Point of Care was founded in 1900 and is headquartered in Waukegan, United States. Operations focus on the medical diagnostics sector, with products developed for point-of-care testing worldwide. Services include COVID-19 antigen self-tests, glycated hemoglobin monitoring for diabetes management, and detection tools for infectious diseases. The companys domain supports global access to these diagnostic solutions.
Abbott Global Point of Care offers i-STAT CHEM8+ Cartridge, CHOLESTECH LDX™ Analyzer, Afinion™ 2, and Panbio™ COVID-19 Antigen Self-Test.
Abbott Global Point of Care has made 12 acquisitions, including Binax, CanAm Care, and Cholestech.
Abbott Global Point of Care has 1 investor. Key investors include European Union.